Full Name
Jaime Guidry Auvil
Job Title
Director, Office of Data Sharing
Company
NIH
Speaker Bio
Dr. Jaime M. Guidry Auvil, the Director of the Office of Data Sharing (ODS) within the National Cancer Institute (NCI), oversees the NCI strategy and approach to development, interpretation and implementation of data sharing and public access policies in cancer research. Dr. Guidry Auvil has led critical, high profile data sharing initiatives for NCI and NIH, including large-scale pediatric cancer research through Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative, Gabriella Miller Kids First Pediatric Research Program, and current flagship program for NCI, the Childhood Cancer Data Initiative (CCDI).
Dr. Guidry Auvil is well-published and provides expertise in optimizing data for cancer research as part of several advisory committees within and across United States federal agencies and international organizations. Dr. Guidry Auvil has held scientific research and regulatory positions in industry, academia and government focusing on healthcare biobanking for infectious disease and cancer, as well as research in mental health, addiction and post-traumatic stress. Dr. Guidry Auvil received her doctorate in Tumor Biology from Georgetown University, where she further holds a patent for a small molecule inhibitor targeting adhesion proteins in bone cancer metastases.
Dr. Guidry Auvil is well-published and provides expertise in optimizing data for cancer research as part of several advisory committees within and across United States federal agencies and international organizations. Dr. Guidry Auvil has held scientific research and regulatory positions in industry, academia and government focusing on healthcare biobanking for infectious disease and cancer, as well as research in mental health, addiction and post-traumatic stress. Dr. Guidry Auvil received her doctorate in Tumor Biology from Georgetown University, where she further holds a patent for a small molecule inhibitor targeting adhesion proteins in bone cancer metastases.
Speaking At